TGF‐β may control the switch between tumorigenic growth and “stem cell/mesenchymal” potentially drug‐resistant states

Publisher: John Wiley & Sons Inc

E-ISSN: 1529-8019|28|3|177-178

ISSN: 1396-0296

Source: DERMATOLOGIC THERAPY, Vol.28, Iss.3, 2015-05, pp. : 177-178

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next